The Impact of Ayahuasca on Suicidality: Results From a Randomized Controlled Trial.
Zeifman, R., Palhano-Fontes, F., Hallak, J., Nunes, E. A., Maia-de-Oliveira, J. P., & de Araujo, D. B. | Frontiers in Pharmacology | 19 November 2019
Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects.
Holze, F., Vizeli, P., Müller, F., Ley, L., Duerig, R., Varghese, N., ... & Liechti, M. E. | Neuropsychopharmacology | 16 November 2019
High-dose ketamine infusion for the treatment of posttraumatic stress disorder in combat veterans.
Ross, C., Jain, R., Bonnett, C. J., & Wolfson, P. | Annals of clinical psychiatry: official journal of the American Academy of Clinical Psychiatrists | 1 November 2019
Searching for Treatments for Cocaine Use Disorder: The Quest Continues.
Brady, K. T. | American Journal of Psychiatry | 1 November 2019
Philanthropists Fund Johns Hopkins Center for Study of Psychedelics
Rubin, R. | Jama | 31 October 2019
Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer.
dos Santos, R. G., Bouso, J. C., & Hallak, J. E. | BMC psychiatry | 28 October 2019
Esketamine Prevents Treatment-Resistant Depression Relapse.
Slomski, A. | Jama | 22 October 2019
The ethics of psychedelic research in disorders of consciousness.
Peterson, A., Tagliazucchi, E., & Weijer, C. | Neuroscience of Consciousness | 9 October 2019
Acute effects of lysergic acid diethylamide (LSD) on resting brain function.
Müller, F., & Borgwardt, S. | Swiss Medical Weekly | 30 September 2019
The psychedelic renaissance: the next trip for psychiatry?
Kelly, J. R., Baker, A., Babiker, M., Burke, L., Brennan, C., & O’Keane, V. | Irish journal of psychological medicine | 23 September 2019